Brighter AB (publ) announced that it together with Padjadjaran University have signed a collaboration agreement to use Actiste Mini for a research project in two West Java hospitals. For a period of six months, 100 patients will use Actiste Mini to monitor their blood glucose levels. Padjadjaran University is responsible for coordinating the study, including training healthcare professionals and patients, gathering data, and providing feedback to Brighter. The research project has its origins in a request from West Java’s governor, who asked Swedish companies for support amid the Covid-19 pandemic. Since then, Brighter has been working to determine an appropriate way to help out.